Stock Price Forecast

March 15, 2024


Forecasted Returns

7 Days Predict

30 Days Predict

90 Days Predict


Forecasted Market-Excess Returns

7 Days Predict

30 Days Predict

90 Days Predict

Loading CRISPR Therapeutics AG chart...

About the Company

CRISPR Therapeutics is a leading gene editing company focused on developing transformative gene-based medicines for serious diseases using its proprietary CRISPR/Cas9 platform. CRISPR/Cas9 is a revolutionary gene editing technology that allows for precise, directed changes to genomic DNA. CRISPR Therapeutics has established a portfolio of therapeutic programs across a broad range of disease areas including hemoglobinopathies, oncology, regenerative medicine and rare diseases. To accelerate and expand its efforts, CRISPR Therapeutics has established strategic collaborations with leading companies including Bayer, Vertex Pharmaceuticals and ViaCyte, Inc. CRISPR Therapeutics AG is headquartered in Zug, Switzerland, with its wholly-owned U.S. subsidiary, CRISPR Therapeutics, Inc., and R&D operations based in Cambridge, Massachusetts, and business offices in San Francisco, California and London, United Kingdom. For more information, please visit www.crisprtx.com.

CEO

Samarth Kulkarni

Exchange

NASDAQ

Website

www.crisprtx.com

$888M

Total Revenue

304

Employees

$6B

Market Capitalization

-19.47

Price/Earning ratio

Fundamental Data and Insider Transactions (Quarterly data) Full Screen

Loading the fundamentals chart...

Latest $CRSP News

Insider Sell: CFO Raju Prasad Sells Shares of CRISPR Therapeutics AG (CRSP)

2h ago, source:

CRISPR Therapeutics AG (NASDAQ:CRSP) is a biotechnology company focused on developing transformative gene-based medicines for ...

Is It Too Late to Buy CRISPR Therapeutics Stock?

2d ago, source:

CRISPR Therapeutics' crowning achievement, at least so far, has been the approval of Casgevy, a one-time curative therapy for ...

CRISPR Therapeutics stock on track for eighth straight session of losses

on MSN ago, source:

CRISPR Therapeutics AG (NASDAQ:CRSP) shares are trading in the red for the eighth consecutive day on Friday. Stock down 2.73% ...

CRISPR Therapeutics AG: CRISPR Therapeutics Proposes New Appointment to the Board of Directors

5mon ago, source:

CRISPR Therapeutics (Nasdaq: CRSP), a biopharmaceutical company focused on creating transformative gene-based medicines for serious diseases ...

Beam Therapeutics Bolts Higher on Gene Therapy Licensing Payments

12d ago, source: MarketBeat on MSN

Beam Therapeutics Inc. (NASDAQ: BEAM) is a biotech company that specializes in developing precision gene therapies for hereditary diseases. The medical sector company is a pioneer in a proprietary ...

Analysts Offer Insights on Healthcare Companies: Ionis Pharmaceuticals (IONS), Edwards Lifesciences (EW) and Aveanna Healthcare Holdings (AVAH)

18h ago, source:

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Ionis Pharmaceuticals (IONS – Research ...

Missed Out on CRISPR Therapeutics? My Best Gene-Editing Stock to Buy and Hold

21d ago, source: The Motley Fool on MSN

The hunt for winning biotech stocks never truly ends, and it's easy to see why. Over the last five years, shares of the gene-editing company CRISPR Therapeutics(NASDAQ: CRSP) are up by 146%, easily ...

Cytokinetics drifts lower as CEO touts standalone strategy

on MSN ago, source:

Cytokinetics (CYTK) stock slips after CEO suggests potential for upside without relying solely on a takeover, highlighting ...

7 Top-Performing Stocks to Buy Now

12d ago, source: Morningstar

Anyone who invested in Equitrans Midstream ETRN—one of the largest natural gas pipeline companies in the US—at this time last year has enjoyed an impressive total return of nearly 80% since. And it’s ...

Cathie Wood's Ark Invest Keeps Dumping Coinbase Shares Amid Bitcoin, Crypto Buzz

6d ago, source:

Cathie Wood-led Ark Invest made a significant move by offloading a substantial number of shares in Coinbase Global Inc ...

Vertex hits speed bump in getting CRISPR sickle cell therapy covered in U.K.

4d ago, source: STAT

The U.K.’s cost-effectiveness watchdog said it is not yet recommending Vertex’s CRISPR therapy for sickle cell, saying it has ...

CRSP Apr 2024 68.000 put

2d ago, source: Yahoo Finance

ZUG, Switzerland and BOSTON, March 13, 2024 (GLOBE NEWSWIRE) -- CRISPR Therapeutics (Nasdaq: CRSP), a biopharmaceutical company focused on creating transformative gene-based medicines for serious ...

Latest Neutral (free) Forecasts

STRONG BUY BUY NEUTRAL SELL STRONG SELL ALL

Loading the latest forecasts...

My Portfolio

Loading your portfolio...